
28/08/2025
Shockwave IVL - Coronary
Procedural success and safety advantages have been demonstrated in heavily calcified coronary arteries using IVL.
𝗪𝗵𝗼 𝗯𝗲𝗻𝗲𝗳𝗶𝘁𝘀 𝗺𝗼𝘀𝘁?
Patients with moderate–severe coronary calcification where traditional balloon angioplasty risks inadequate lesion expansion or vessel injury.
IVL delivers controlled microfractures in calcific plaques at low pressure, enabling better stent delivery and expansion while minimizing trauma.
𝗗𝘂𝗿𝗮𝗯𝗶𝗹𝗶𝘁𝘆 𝗺𝗮𝘁𝘁𝗲𝗿𝘀.
Currently, long-term patency and clinical outcome data for coronary IVL are pending or not sufficiently validated in RCTs; confidently including them would exceed confirmed data.
All major cath labs in Lithuania are equipped with Shockwave IVL for both peripheral and coronary applications.
Prep. Crack. Expand.
🔍 Has your lab integrated Shockwave IVL yet? We’d value hearing your perspective.